Toxaphene‐induced mouse liver tumorigenesis is mediated by the constitutive androstane receptor

Toxaphene was shown to increase liver tumor incidence in B6C3F1 mice following chronic dietary exposure. Preliminary evidence supported a role for the constitutive androstane receptor (CAR) in the mode of action of toxaphene‐induced mouse liver tumors. However, these results could not rule out a role for the pregnane X receptor (PXR) in liver tumor formation. To define further the nuclear receptors involved in this study, we utilized CAR, PXR and PXR/CAR knockout mice (CAR−/−, PXR−/− and PXR−/−/CAR−/−) along with the wild‐type C57BL/6. In this study CAR‐responsive genes Cyp3a11 and Cyp2b10 were induced in the liver of C57BL/6 (wild‐type) mice by toxaphene (30–570‐fold) (at the carcinogenic dose 320 ppm) and phenobarbital (positive control) (16–420‐fold) following 14 days' dietary treatment. In contrast, in CAR−/− mice, no induction of these genes was seen following treatment with either chemical. Cyp3a11 and Cyp2b10 were also induced in PXR−/− mice with toxaphene and phenobarbital but were not changed in treated PXR−/−/CAR−/− mice. Similarly, induction of liver pentoxyresorufin‐O‐deethylase (CAR activation) activity by toxaphene and phenobarbital was absent in CAR−/− and PXR−/−/CAR−/− mice treated with phenobarbital or toxaphene. Ethoxyresorufin‐O‐deethylase (EROD, represents aryl hydrocarbon receptor activation) activity in CAR−/− mice treated with toxaphene or phenobarbital was increased compared with untreated control, but lower overall in activity in comparison to the wild‐type mouse. Liver EROD activity was also induced by both phenobarbital and toxaphene in the PXR−/− mice but not in the PXR−/−/CAR−/− mice. Toxaphene treatment increased 7‐benzyloxyquinoline activity (a marker for PXR activation) in a similar pattern to that seen with pentoxyresorufin‐O‐deethylase. These observations indicate that EROD and PXR activation are evidence, as expected, of secondary overlap to primary CAR receptor activation. Together, these results definitively show that activation of the CAR nuclear receptor is the mode of action of toxaphene‐induced mouse liver tumors. Copyright © 2017 John Wiley & Sons, Ltd.

[1]  W. Kilgore,et al.  Toxaphene. , 2020, Report on carcinogens : carcinogen profiles.

[2]  J. Klaunig,et al.  Mechanistic Investigation of Toxaphene Induced Mouse Liver Tumors. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  R. J. Price,et al.  Mode of action analysis for pesticide-induced rodent liver tumours involving activation of the constitutive androstane receptor: relevance to human cancer risk. , 2015, Pest management science.

[4]  Virunya S Bhat,et al.  Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  J. Corton,et al.  Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study , 2014, Critical reviews in toxicology.

[6]  T. Starr,et al.  Mode of action and dose–response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study , 2014, Critical reviews in toxicology.

[7]  Wen Xie,et al.  Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator , 2014, Critical reviews in toxicology.

[8]  L. Carbone Pain management standards in the eighth edition of the Guide for the Care and Use of Laboratory Animals. , 2012, Journal of the American Association for Laboratory Animal Science : JAALAS.

[9]  C. Wolf,et al.  Transcriptional Regulation of Cytochrome P450 Genes , 2012 .

[10]  Mirjam Luijten,et al.  Transgenic animal models in toxicology: historical perspectives and future outlook. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  J. Goodman,et al.  Risk Assessment of Toxaphene and its Breakdown Products: Time for a Change? , 2008, Critical reviews in toxicology.

[12]  G. Perdew,et al.  Aryl‐hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver , 2007, Hepatology.

[13]  M. Negishi,et al.  CAR and PXR: The xenobiotic-sensing receptors , 2007, Steroids.

[14]  S. D. Turner,et al.  Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[15]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[16]  D. Brusick,et al.  Reevaluation of the cancer potency factor of toxaphene: recommendations from a peer review panel. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  D. Waxman,et al.  P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. , 1999, Archives of biochemistry and biophysics.

[18]  T. Sakuma,et al.  Induction of CYP1A2 by phenobarbital in the livers of aryl hydrocarbon-responsive and -nonresponsive mice. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[19]  A. Brouwer,et al.  Environmental occurrence, analysis, and toxicology of toxaphene compounds. , 1999, Environmental Health Perspectives.

[20]  A. Brouwer,et al.  Environmental Occurrence, Analysis and Toxicology of Toxaphene Compounds , 1999 .

[21]  L. Corcos,et al.  Phenobarbital induces cytochrome P4501A2 hnRNA, mRNA and protein in the liver of C57BL/6J wild type and aryl hydrocarbon receptor knock‐out mice , 1998, FEBS letters.

[22]  B. W. Penman,et al.  Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. , 1997, Analytical biochemistry.

[23]  H. Navarro,et al.  Toxicological profile for toxaphene , 1996 .

[24]  T. Goldsworthy,et al.  Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump. , 1990, Carcinogenesis.

[25]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[26]  J. Casida,et al.  Toxaphene, a complex mixture of polychloroterpenes and a major insecticide, is mutagenic. , 1979, Science.

[27]  S S Epstein,et al.  Detection of chemical mutagens by the dominant lethal assay in the mouse. , 1972, Toxicology and applied pharmacology.

[28]  Vicki L Dellarco,et al.  Mode of action in relevance of rodent liver tumors to human cancer risk. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  Alison Willis,et al.  Mode of Action , 2020, Definitions.

[30]  E. Zeiger,et al.  Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. , 1986, Environmental mutagenesis.

[31]  B. Jansson,et al.  Analysis of toxaphene (PCC) and chlordane in biological samples by NCI mass spectrometry. , 1983, International journal of environmental analytical chemistry.

[32]  Bioassay of toxaphene for possible carcinogenicity. , 1979, National Cancer Institute carcinogenesis technical report series.

[33]  T. Nash Chemical Carcinogenesis , 1957, Nature.